{"id":"652992023103-09","name":"European Society for Blood and Marrow Transplantation","registrationDate":"2016-08-23T11:55:42.557+01:00","category":3,"subCategory":2,"legal":"not for profit foundation registered in The Netherlands. See http://www.ebmt.org/Contents/Footer/Pages/ANBI-data.aspx for further details","web":"http://www.ebmt.org","country":"Netherlands","headAddress":"EBMT","headCity":"Leiden","headPostCode":"2333 AA","headPhone":"(31)7 15 26 47 46","boss":"Andreu Gusi","bossTitle":"Mr","bossPosition":"Executive Director","membersCount":1,"membersFTE":"0.25","membership":"Common representation of Substances of Human Originâ€™s (SoHO) - see http://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=501652723968-72&#xd;\nAlliance for Harmonisation of Cellular Therapy (AHCTA) www.ahcta.org&#xd;\nWorldwide Network for Blood &amp; Marrow Transplantation (WBMT) www.wbmt.org","memberOrga":"EBMT members are centres that perform bone marrow transplantation. Physicians, nurses, scientists, data managers and quality managers working in those centres and listed as team members are considered members. &#xd;\n&#xd;\nFurthermore, our centre members can be divided into two categories: full members, or associate members. Our full members generously commit to submitting data on all patients treated in their centres on an annual basis, and enjoy the benefits of voting rights and eligibility for JACIE accreditation.&#xd;\n&#xd;\nProvisional centres are new members which are pending approval at the General Assembly Meeting during the EBMT Annual Meeting.&#xd;\n&#xd;\nEBMT also has individual members. &#xd;\n&#xd;\nCorporate membership is available to pharmaceutical and other companies in the field of blood cancers. See http://www.ebmt.org/Contents/Members-Sponsors/Sponsors/Listofcorporatesponsors/Pages/List-of-corporate-sponsors.aspx for the current list.&#xd;\n&#xd;\nFull details can be found at http://www.ebmt.org/Contents/Members-Sponsors/Members/Membershipcategoriesandbenefits/Pages/Membership-categories-and-benefits.aspx","goal":"To save the lives of patients with blood cancers and other life-threatening diseases by advancing the fields of blood and marrow transplantation and cell therapy worldwide through science, education and advocacy.&#xd;<br />&#xd;<br />The EBMT vision for the forthcoming years encompasses:&#xd;<br />&#xd;<br />Enhancing the scientific output of the organisation through strong support from the working parties to exploit the potential of the registry, and continue generating high quality retrospective and prospective data both in the autologous and allogeneic settings&#xd;<br />&#xd;<br />Collaborating with the different disease-oriented cooperative groups&#xd;<br />&#xd;<br />Widening the Annual Meeting through the incorporation of high level basic and translational research sessions&#xd;<br />&#xd;<br />Developing a broad annual educational events agenda in order to address more focused research and clinical topics&#xd;<br />&#xd;<br />Advocating for patients before the health authorities in order to maintain a high standard of care high quality research","acronym":"EBMT","interests":"Information Society, Public Health, Research and Technology","euInitiatives":"EU Directives on Tissues and Cells&#xd;<br />Advanced Therapy Medicinal Product regulations&#xd;<br />Horizon 2020 funding opportunities&#xd;<br />Public Health Programme&#xd;<br />European Reference Networks for rare diseases&#xd;<br />European Medicines Agency initiatives on patient registries&#xd;<br />Innovative Medicines Initiative&#xd;<br />Health Technology Assessment","lastUp":"2017-07-20T16:47:47.704+01:00","customers":"","costAbsolu":"","costRange":"10000-24999","turnoverAbsolu":0,"turnoverRange":""}